GGrantIndex
← Search

THERAPEUTIC EFFECTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONIST ON COMBAT-INDUCED PROLIFERATIVE VITREORETINOPATH

$267,544FY2025Defense Health AgencyDOD

Metis Foundation, San Antonio TX

Investigators

View source on USAspending →
THERAPEUTIC EFFECTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONIST ON COMBAT-INDUCED PROLIFERATIVE VITREORETINOPATH · GrantIndex